Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/09/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Remedium Lifecare Ltd (formerly Roxy Exports Limited) has informed BSE that its Board of Directors will meet on September 22, 2025. The Board will consider three key items: (1) a proposal to change the company's name, subject to approvals; (2) an increase in the authorised share capital along with related amendments to the Memorandum of Association, subject to shareholder approval; and (3) a proposal to raise further capital, potentially through a Qualified Institutions Placement (QIP) or a Rights Issue. The company has not disclosed specific quantum of capital raise or pricing details at this stage. All agenda items remain subject to shareholder and regulatory approvals.
The agenda suggests the company may be preparing for a potential fund-raising exercise and a corporate identity change, which could lead to dilution for existing shareholders depending on the size and structure of the capital raise. Investors should watch for further details on the QIP or Rights Issue terms, pricing, and the rationale behind the name change.